NXGN
NextGen Healthcare Inc
Price:
23.94
USD
Volume:
3,151,660
United States | Health Care Technology
Discounted Cash Flow
Trading Multiples
Peter Lynch Fair Value
Earnings Power Value
Dividend Discount Model
WACC
NXGN EV/EBITDA
-55.6 %
Upside
As of 2025-05-17, the EV/EBITDA ratio of NextGen Healthcare Inc (NXGN) is 22.8. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NXGN's latest enterprise value is 1,820 mil USD. NXGN's TTM EBITDA according to its financial statements is 80 mil USD. Dividing these 2 quantities gives us the above NXGN EV/EBITDA ratio.
| Range | Selected | |
| Trailing EV/EBITDA multiples | 10.7x - 13.3x | 12.1x |
| Forward EV/EBITDA multiples | 14.4x - 16.3x | 14.9x |
| Fair Price | 8.97 - 12.65 | 10.62 |
| Upside | -62.5% - -47.2% | -55.6% |
23.94 USD
Stock Price
10.62 USD
Fair Price
| (USD in millions except Fair Price) | |||
| Trailing | Forward | ||
| Market Cap (USD mil) | EV/EBITDA | EV/EBITDA | |
| NextGen Healthcare Inc | 1,606 | 22.8x | 32.1x |
| Cerner Corp | 27,916 | 19.2x | 18.3x |
| Computer Programs and Systems Inc | 134 | 5.3x | 7.1x |
| Evolent Health Inc | 1,037 | 11.9x | 43.3x |
| HealthStream Inc | 870 | 13x | 15x |
| Inovalon Holdings Inc | 7,984 | 32.7x | 52.6x |
| Allscripts Healthcare Solutions Inc | 737 | 6.5x | 14.8x |
| Omnicell Inc | 1,310 | 12.3x | 13.8x |
| Vigil Health Solutions Inc | 9 | 8.2x | 9.2x |
| VisualMED Clinical Solutions Corp | 0 | 1.9x | 1.8x |
| Industry median | 12.1x | 14.9x | |
| (*) EBITDA | 80 | 57 | |
| Enterprise value | 965 | 844 | |
| (-) Net debt | 214 | 214 | |
| Equity value | 751 | 631 | |
| (/) Outstanding shares | 67 | 67 | |
| Fair price | 11 | 9 | |